Invention Grant
- Patent Title: Self-limiting viral vectors encoding nucleases
-
Application No.: US15737918Application Date: 2016-06-20
-
Publication No.: US10662440B2Publication Date: 2020-05-26
- Inventor: Derek Jantz , James Jefferson Smith , Michael G. Nicholson
- Applicant: Precision BioSciences, Inc. , Derek Jantz , James Jefferson Smith , Michael G. Nicholson
- Applicant Address: US NC Durham
- Assignee: Precision BioSciences, Inc.
- Current Assignee: Precision BioSciences, Inc.
- Current Assignee Address: US NC Durham
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/US2016/038434 WO 20160620
- International Announcement: WO2016/205825 WO 20161222
- Main IPC: C12N15/63
- IPC: C12N15/63 ; C12N15/85 ; C07H21/04 ; C12N15/86 ; C12N9/22 ; A61K38/00

Abstract:
Disclosed herein are viral vectors for use in recombinant molecular biology techniques. In particular, the present disclosure relates to self-limiting viral vectors comprising genes encoding site-specific endonucleases as well as recognition sequences for site-specific endonucleases such that expression of the endonuclease in a cell cleaves the viral vector and limits its persistence time. In some embodiments, the viral vectors disclosed herein also carry directives to delete, insert, or change a target sequence.
Public/Granted literature
- US20180171357A1 SELF-LIMITING VIRAL VECTORS ENCODING NUCLEASES Public/Granted day:2018-06-21
Information query
IPC分类: